Following the market opening Wednesday, the Dow traded down 0.43% to 33,839.68 while the NASDAQ rose 0.10% to 14,104.41. The S&P also rose, gaining 0.19% to 4,194.68.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,176,050 cases with around 573,380 deaths. India confirmed a total of at least 17,997,110 cases and 201,180 deaths, while Brazil reported over 14,441,560 COVID-19 cases with 395,020 deaths. In total, there were at least 148,763,560 cases of COVID-19 worldwide with more than 3,136,870 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Communication services shares climbed by 2.3% on Wednesday. Meanwhile, top gainers in the sector included Alphabet Inc. (NASDAQ:GOOG), up 6%, and AirNet Technology Inc. (NASDAQ:ANTE), up 6%.

In trading on Wednesday, information technology shares fell 0.5%.

Top Headline

Google parent company Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL) reported better-than-expected earnings for its first quarter on Tuesday.

Alphabet reported revenue of $55.3 billion in the first quarter, beating estimates of $51.7 billion. Earnings per share of $26.29 beat estimates of $15.88.

Equities Trading UP

Aurora Mobile Limited (NASDAQ:JG) shares shot up 23% to $4.3197 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per share.

Shares of Creatd, Inc. (NASDAQ:CRTD) got a boost, shooting 22% to $4.55 after the company reported strategic investment in Untamed Photographer, NFT Collaboration, and Vocal Community and Challenge Sponsorships.

Boxlight Corporation (NASDAQ:BOXL) shares were also up, gaining 17% to $2.85. Maxim Group reiterated Boxlight with a Buy and announced a $6 price target.

Check out these big movers of the day

Equities Trading DOWN

Protalix BioTherapeutics, Inc. (NYSE:PLX) shares tumbled 41% to $3.43. Protalix BioTherapeutics and partner Chiesi announced that they received a complete response letter from the FDA regarding the biologics license application, seeking accelerated approval of pegunigalsidase alfa for the proposed treatment of adult patients with Fabry disease.

Shares of Urban Tea, Inc. (NASDAQ:MYT) were down 37% to $2.92 after the company reported pricing of approximately $25million registered direct


Comments are closed.